Could a common heart drug cut COPD hospitalizations?
Disease control
Completed
This trial tests whether adding the beta-blocker metoprolol to standard care can reduce a combined risk of death, COPD flare-ups, and heart-related hospitalizations in people with COPD who do not have known heart disease. About 1,700 adults with COPD will receive either metoprolo…
Phase: PHASE4 • Sponsor: Ole Frobert, MD, PhD • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC